Results 81 to 90 of about 20,877 (202)
Therapeutic Approach to Primary Tic Disorders and Associated Psychiatric Comorbidities
Brain SciencesBackground/Objectives: The treatment of tics and psychiatric comorbidities is crucial when they affect the patient’s well-being and relationships. However, the optimal pharmacological treatment (PT) tailored to each patient’s phenotype remains unclear ...
Irene Berzosa-Gonzalez +4 more
doaj +1 more source
Paroxysmal Dystonic Choreoathetosis
Pediatric Neurology Briefs, 2000 The clinical characteristics of paroxysmal dystonic choreoathetosis (PDC) in 20 affected members of a large British family are reported from the Institute of Neurology, Queen Square, and the MR Unit, Hammersmith Hospital, London, UK.
J Gordon Millichap
doaj +1 more source
Current Issues in Pharmacy and Medical Sciences, 2020 Utilizing the batch Diazotization coupling reaction and the cloud point extraction kinetic spectrophotometric method, trace and Ultra trace amounts from reducing Nitrazepam and Clonazepam were evaluated by way of using 2,5-dimethoxyaniline as a new ...
Mahdi Muna Iskandar +1 more
doaj +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by motor, oculomotor and cognitive impairments. Yet disentangling cognitive deficits from motor and oculomotor dysfunction remains a diagnostic and methodological challenge.
Indira Garcia‐Cordero +12 more
wiley +1 more source
Low Doses of Clonazepam in the Treatment of Panic Disorder*
, 1991 In order to assess the efficacy of a high-potency benzodiazepine in the treatment of panic disorder, an open trial was conducted with clonazepam. Clonazepam was administered in relatively low doses and, after four weeks, was shown to be effective in ...
E. Griez +4 more
core +1 more source
Journal of Geriatric Mental Health, 2018 Benzodiazepines (BZDs) remain the mainstay in the management of withdrawal arising out of BZD use disorders. The choice of detoxifying agent is determined by the duration of action and also by the metabolic properties of the drug.
Vrinda Saxena, Robin Victor, Arghya Pal
doaj +1 more source
JAK2 Variant and Parkinsonian Syndromes: Coincidence or Pathophysiological Link?
Movement Disorders Clinical Practice, EarlyView.Abstract Background JAK2 variants are a hallmark of myeloproliferative neoplasms (MPNs), including polycythemia vera and essential thrombocythemia. These disorders are often associated with thrombotic and inflammatory complications. From a movement disorder perspective, chorea is a rare but well‐recognized neurological occurrence in this context ...
Elena Ardila Jurado +5 more
wiley +1 more source
Low-Dose Clonazepam Effect on Epileptiform Activity
, 2000 The effect of low-dose clonazepam (CZP) on 24-hour long-term EEG recordings in 15 children with epilepsy was evaluated at the Karolinska Hospital, Stockholm ...
J Gordon Millichap
core +1 more source
Tablet splitting: implications in clonazepam dose adjustment?
, 2018 Tablet splitting is particularly interesting for dose tapering and slow dose titration, especially in psychiatric and geriatric communities. The objective of this study was to investigate the accuracy and precision of splitting clonazepam tablets using a
Eserian, Jaqueline Kalleian +3 more
core +1 more source
Movement Disorders, EarlyView.Abstract Aims To conduct a case–control study to investigate melanopsin‐mediated post‐illumination pupillary response (PIPR) in patients with Parkinson's disease (PD), video‐polysomnography‐confirmed isolated/idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD), and age‐matched healthy controls (HC). Methods PIPR was measured at 6 s after
Joey W.Y. Chan +16 more
wiley +1 more source